NCT00004339View on ClinicalTrials.gov

Study of Tetrathiomolybdate in Patients With Wilson Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 31, 1994

Conditions
Wilson Disease
Interventions
DRUG

tetrathiomolybdate

DRUG

trientine

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

National Center for Research Resources (NCRR)

NIH